Free tool
FAERS Monitor: Gamifant
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming BLA 761107 or its brand name (Gamifant, Emapalumab-Lzsg). Reports on generic versions are filed under their own applications.
Reports
237
Serious
209
88% of reports
Hospitalization
67
Death reported
106
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- off label use94
- haemophagocytic lymphohistiocytosis72
- condition aggravated60
- drug ineffective32
- death29
- septic shock21
- epstein-barr virus infection14
- multiple organ dysfunction syndrome14
- adenovirus infection13
- hypertension13
- pyrexia13
- serum ferritin increased12
- still^s disease10
- respiratory failure9
- sepsis9
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2019 | 17 |
| 2020 | 15 |
| 2021 | 12 |
| 2022 | 18 |
| 2023 | 18 |
| 2024 | 31 |
| 2025 | 62 |
| 2026 | 64 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,053,922 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| haemophagocytic lymphohistiocytosisSignal | 72 | 859.7 | 708.0 | 60,336 |
| adenovirus infectionSignal | 13 | 399.6 | 235.3 | 4,757 |
| serum ferritin increasedSignal | 12 | 202.4 | 116.5 | 2,203 |
| epstein-barr virus infectionSignal | 14 | 199.3 | 119.8 | 2,563 |
| multiple organ dysfunction syndromeSignal | 14 | 43.9 | 26.4 | 545 |
| septic shockSignal | 21 | 42.9 | 28.5 | 818 |
| condition aggravatedSignal | 60 | 17.5 | 14.1 | 931 |
| respiratory failureSignal | 9 | 11.0 | 5.8 | 72 |
| off label useSignal | 94 | 9.5 | 8.1 | 740 |
| sepsisSignal | 9 | 7.2 | 3.8 | 42 |
| hypertensionSignal | 13 | 5.4 | 3.2 | 43 |
| pyrexiaSignal | 13 | 3.3 | 2.0 | 19 |
| deathSignal | 29 | 3.0 | 2.1 | 38 |
| drug ineffectiveSignal | 32 | 2.2 | 1.6 | 20 |
| still^s disease | 10 | 0.0 | 0.0 | 801,736 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.